These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17240844)

  • 1. [Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors].
    Yamauchi M; Hiraoka S; Imanishi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):193-8. PubMed ID: 17240844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Yamauchi M; Tatebayashi T; Nagase K; Kojima M; Imanishi T
    Pharmacol Biochem Behav; 2004 Aug; 78(4):683-9. PubMed ID: 15301922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors.
    Yamauchi M; Miyara T; Matsushima T; Imanishi T
    Brain Res; 2006 Jan; 1067(1):164-9. PubMed ID: 16360124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
    den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
    Fujitsuka N; Asakawa A; Hayashi M; Sameshima M; Amitani H; Kojima S; Fujimiya M; Inui A
    Biol Psychiatry; 2009 May; 65(9):748-59. PubMed ID: 19058784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.
    Sarkar A; Chachra P; Vaidya VA
    Biol Psychiatry; 2014 Dec; 76(11):858-68. PubMed ID: 24315410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.
    Nic Dhonnchadha BA; Ripoll N; Clénet F; Hascoët M; Bourin M
    Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological basis of anxiety disorders and serotonergic anxiolytics].
    Inoue T; Izumi T; Li XB; Huang JZ; Kitaichi Y; Nakagawa S; Koyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):125-31. PubMed ID: 15291241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 5-HT
    Vilela-Costa HH; Maraschin JC; Casarotto PC; Sant'Ana AB; de Bortoli VC; Vicente MA; Campos AC; Guimarães FS; Zangrossi H
    Behav Brain Res; 2021 Apr; 404():113159. PubMed ID: 33571572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors.
    Honda M; Uchida K; Tanabe M; Ono H
    Neuropharmacology; 2006 Sep; 51(4):866-72. PubMed ID: 16846619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
    J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent trends in pharmacotherapy for anxiety disorders].
    Tajima O
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):133-6. PubMed ID: 15291242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
    Stewart A; Maity B; Wunsch AM; Meng F; Wu Q; Wemmie JA; Fisher RA
    FASEB J; 2014 Apr; 28(4):1735-44. PubMed ID: 24421401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.
    Rojas-Corrales MO; Gibert-Rahola J; Mico JA
    Psychopharmacology (Berl); 2007 Feb; 190(2):221-31. PubMed ID: 17102981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test.
    Schreiber R; Melon C; De Vry J
    Psychopharmacology (Berl); 1998 Feb; 135(4):383-91. PubMed ID: 9539263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
    Vaswani M; Linda FK; Ramesh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
    Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT2C receptor as a target for mood disorders.
    Serretti A; Artioli P; De Ronchi D
    Expert Opin Ther Targets; 2004 Feb; 8(1):15-23. PubMed ID: 14996615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.